Technical Analysis for BIMUF - Pascal Biosciences Inc

Grade Last Price % Change Price Change
grade F 0.0954 -14.13% -0.0157
BIMUF closed down 14.13 percent on Friday, October 18, 2019, on 14 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical BIMUF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -14.13%

Older signals for BIMUF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Pascal Biosciences Inc., a drug discovery and development company, researches and develops biotechnology products for the treatment of cancer and for the enhancement of immune system in Canada. Its research programs include the development of Anti-VpreB, a therapeutic monoclonal antibody for treatment of B-cell precursor acute lymphoblastic leukemia in collaboration with the University of New Mexico; optimization of novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company has a collaboration agreement with the University of British Columbia. Pascal Biosciences Inc. is headquartered in Vancouver, Canada.
Medicine Medical Specialties Cancer Treatment Of Cancer Immunology Cancers Drug Discovery Autoimmune Diseases Immune System Cancer Immunotherapy Infections Monoclonal Antibody Acute Lymphoblastic Leukemia Biotechnology Products University Of British Columbia
Is BIMUF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.6611
52 Week Low 0.0954
Average Volume 7,093
200-Day Moving Average 0.0
50-Day Moving Average 0.1535
20-Day Moving Average 0.1217
10-Day Moving Average 0.1215
Average True Range 0.0093
ADX 21.01
+DI 29.1954
-DI 58.1609
Chandelier Exit (Long, 3 ATRs ) 0.1121
Chandelier Exit (Short, 3 ATRs ) 0.1233
Upper Bollinger Band 0.1413
Lower Bollinger Band 0.1021
Percent B (%b) -0.17
BandWidth 32.210353
MACD Line -0.0118
MACD Signal Line -0.012
MACD Histogram 0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0954
Resistance 3 (R3) 0.0954 0.0954 0.0954
Resistance 2 (R2) 0.0954 0.0954 0.0954 0.0954
Resistance 1 (R1) 0.0954 0.0954 0.0954 0.0954 0.0954
Pivot Point 0.0954 0.0954 0.0954 0.0954 0.0954
Support 1 (S1) 0.0954 0.0954 0.0954 0.0954 0.0954
Support 2 (S2) 0.0954 0.0954 0.0954 0.0954
Support 3 (S3) 0.0954 0.0954 0.0954
Support 4 (S4) 0.0954